The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Wow. Double wow
Over 900,000 patients worldwide have received the information provided by the Oncotype DX assay.
Duopolies tend to price match or find equilibrium fairly quickly. So if TILS have ASP of $3000 (25% price drop) and 30% market share = revenue of 50,000 x $3000
= a lot ($150M). Given it is a better test they might launch at a premium and why would you run such a diagnostic and not just get the best.
Am I missing something - the market knows all this so why is SP not higher?
I can only presume because there is a $20mil share sale/capital raise happening. Its been going on since 60p and a lot around 1115/120 lvls. Once this is over - Bingo.. However after this interview, I would presume ThinkEquity will raise the selling price of the shares and raise all of the $20mil a lot quicker.
I've loaded up my order for tomorrow 118 Bid 2K worth..
There are IIs in TILS and they are not really flying under radar.
I know the therapeutics are high risk as in any biotech but I have a feeling I am missing something. I topped to last week but think I might do so again if I can understand what is holding SP back
The atm’s have held the sp back, a few more weeks and they will be done and you won’t get these under £1.50 imo
We have had 2 reasons why the shareprice has been held back.
1.) ATM's to raise up to £16.2million by end July.
2.)Quils Institutional Investor selling due to their requirement to raise funds for their business reasons so reduce their holding in tils, not anything to do with not liking tils. ( but I've not got the right wording. )
For clarity, each ADR on Nas equals 5 shares on Aim, therefore to compute between the 2 exchanges, divide the NAS shareprice by 5 and multiply by 0.81 (currently ).
Hope that helps.
Gla ( no luck required )lol.
vbw
So with an ATM I presume the company call the price to sell at - if they know there is news coming out they would hold on. Suggests to me they have plans that will need capital but they can raise when at a price that suits them.
Going to sound nieive but where do you find details of what they are selling at. Thanks for the advice - GLA
Well they employ a company called thinkequity, who have a history of raising funds for this sector. They will be 'advising' what price to sell at etc.. RNS's are issued with the total of funds raised and new shares tradable on the exchange. Since the ATM program a total of approx 11mil more shares are in circulation, some of these are warrant execises . However so far
ATM for may raised $1.8Mil
ATM for Jun raised $2.8Mil
So still a bit to go. : and according to the last RNS see below - They may extend the offering after Jul.
The offering of ADSs pursuant to the Offering Agreement continues to run and will now terminate upon the earlier of: (a) the sale of all of the ADSs subject to the Offering Agreement; (b) the termination of the Offering Agreement by ThinkEquity or the Company, as permitted in accordance with its terms; or (c) 31 July 2020, unless extended.
Sorry, so I dont know for sure the levels or when they are selling as part of the ATM, so you kinda just have to look at the price action and gauge from experience .
https://www.think-equity.com/trading. They can trade on the NYSE , Unless someone here knows the Thinkequity executing broker in the LDN timezone , its all guess work..
Quick look at their balance sheet suggests they are keeping the lights on but issuing equity.
If they didn't generate income from some source then they will have to continue issuing equity
Have I got that right?
Davey - this post seemed to do the trick. Can we have another one on Wednesday
i will certainly oblige rd
A few ATM kicked in US no doubt. Should climb again